Difference between revisions of "Spermatocytic tumour"

Jump to navigation Jump to search
no edit summary
Line 100: Line 100:
NEGATIVE: AE1/AE3, AFP, CD31, CD34, calretinin, hCG, CD3, CD10, CD20, CD30, CD45, GATA3, PLAP, PSA, OCT3/4.
NEGATIVE: AE1/AE3, AFP, CD31, CD34, calretinin, hCG, CD3, CD10, CD20, CD30, CD45, GATA3, PLAP, PSA, OCT3/4.


This tumour (spermatoctyic tumour) was previously known as "spermatocytic seminoma".  The term "spermatocytic seminoma" is no longer recommended by the WHO, presumably as the name may: (1) create confusion with "seminoma" and (2) falsely raise the possibility of a mixed tumour (that develops in the context of GCNIS).
This tumour (spermatoctyic tumour) was previously known as "spermatocytic seminoma".  The term "spermatocytic seminoma" is no longer recommended by the World Health Organization, presumably as the name may: (1) create confusion with "seminoma" and (2) falsely raise the possibility of a mixed tumour (that develops in the context of GCNIS).
</pre>
</pre>


48,860

edits

Navigation menu